OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
Hideki Mori, Gianluca Svegliati‐Baroni, Marco Marzioni, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 647-647
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 23

Good girl goes bad: Understanding how gut commensals cause disease
Priyankar Dey
Microbial Pathogenesis (2024) Vol. 190, pp. 106617-106617
Closed Access | Times Cited: 9

Gut microbiota-derived metabolites and chronic inflammatory diseases
Alejandra Vargas, Benjamin L. Robinson, Kevin Houston, et al.
Exploration of Medicine (2025)
Open Access | Times Cited: 1

Fecal Microbiota Transplantation in NAFLD Treatment
Ludovico Abenavoli, Valentina Maurizi, Emanuele Rinninella, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1559-1559
Open Access | Times Cited: 33

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
Salvatore Pezzino, Maria Sofia, Gloria Faletra, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1622-1622
Open Access | Times Cited: 31

Nutritional Characteristics, Health Impact, and Applications of Kefir
Oladayo Emmanuel Apalowo, Grace A. Adegoye, Teresia Mbogori, et al.
Foods (2024) Vol. 13, Iss. 7, pp. 1026-1026
Open Access | Times Cited: 8

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Maria Rosaria Paravati, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1792-1792
Open Access | Times Cited: 15

Inulin ameliorates metabolic syndrome in high-fat diet-fed mice by regulating gut microbiota and bile acid excretion
Shaoxiong Huang, Shiliang Dong, Lizhen Lin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Emidio Scarpellini, Marialaura Scarcella, Jan Tack, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1386-1386
Open Access | Times Cited: 4

Gut microbial metabolites as a convergence point between autoimmunity and solid tumors
Anu Shibi Anilkumar, Sheena Mariam Thomas, Ramakrishnan Veerabathiran
Gut Microbes Reports (2025), pp. 1-12
Open Access

Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, et al.
(2025) Vol. 2
Open Access

Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism
Chang Sun, Chenguang Qiu, Yanyan Zhang, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4042-4042
Open Access | Times Cited: 10

Dietary Fatty Acid Composition Alters Gut Microbiome in Mice with Obesity-Induced Peripheral Neuropathy
Mohamed Noureldein, Amy E. Rumora, Samuel J. Teener, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 737-737
Open Access

The Role of Gut Microbiome on Glioblastoma Oncogenesis and Malignant Evolution
Zahurin Mohamed, Qiong Wu, Maria A. Jacome, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2935-2935
Open Access

Review of the mechanisms of the biliary-enteric axis in the development of cholangiocarcinoma
Tianhao Shen, Xue Yu, Cheng Zhou, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease
Mykhailo Buchynskyi, Iryna Kamyshna, Iryna Halabitska, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access

Hepatic protein phosphatase 1 regulatory subunit 3G alleviates obesity and liver steatosis by regulating the gut microbiota and bile acid metabolism
Chu Zhang, Wang Gui, Xin Yin, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100976-100976
Open Access | Times Cited: 3

Associations of long-term exposure to particulate matter with gallstone risks in Chinese adults: A large cross-sectional study
Chan Nie, Li Z, Tingting Yang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 252, pp. 114644-114644
Open Access | Times Cited: 7

Systemic Bile Acids Affect the Severity of Acute Pancreatitis in Mice Depending on Their Hydrophobicity and the Disease Pathogenesis
Quang Trung Tran, Matthias Sendler, Mats L. Wiese, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13592-13592
Open Access | Times Cited: 10

Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy
Hao Ma, Yunyang Bao, Shuaishuai Niu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 758-758
Open Access | Times Cited: 6

Relationship between obesity related indicators and non-alcoholic fatty liver disease in children: a systematic review and meta-analysis
Ying He, Liubin Cao, Cheng-Pei Zhou, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 3, pp. 429-444
Open Access | Times Cited: 4

Penthorum chinense Pursh improves type 2 diabetes mellitus via modulating gut microbiota in db/db mice
Jilei Hu, Huibo Xie, Ning Lin, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
Irene Mignini, Linda Galasso, Giulia Piccirilli, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1532-1532
Open Access | Times Cited: 1

Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities
Ricardo Amorim, Pedro Soares, Daniel Chavarria, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116723-116723
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top